Capricorn Fund Managers Ltd has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity holdings as of the close of business on September 30, 2026. The filing lists 138 distinct positions held by the firm, managed from its offices in London and Mumbai. The report was signed by Parth Karia, Head of Risk, and lists the company's address as 2nd Floor, Malta House, 36-38 Piccadilly, London W1J 0DP.
The portfolio includes a mix of large-cap technology, healthcare, and financial services companies. Notable holdings include Alphabet Inc. Class A with 27,107 shares, Amazon.com with 43,132 shares, and Microsoft Corp with 65,520 shares. In the healthcare sector, the firm holds positions in Adaptive Biotechnologies Corp, Biohaven Ltd, and Guardant Health COM.
The filing also details several specific positions with significant share counts. Capricorn holds 132,805,495 shares of Blend Labs Class A, 8,200,000 shares of MaxCyte COM, and 5,374,09 shares of Roivant Sciences Ltd. The firm also holds 500,000 shares of Boost Run Inc-CL A Ord Shs Cl A and 500,000 shares of Flagstar Bank NA Com New.
Additionally, the filing includes several options positions, such as 200 shares of Advanced Micro Devices Inc Call, 5,000 shares of Boost Run Inc Call, and 30,000 shares of iShares TR Call. The report provides a comprehensive list of all equity and option holdings, totaling 138 positions.
